eISSN: 2391-6052
ISSN: 2353-3854
Alergologia Polska - Polish Journal of Allergology
Current issue Archive Manuscripts accepted About the journal Supplements Special issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
3/2020
vol. 7
 
Share:
Share:
abstract:
Review paper

Vaccine against COVID-19 or against SARS-CoV-2 infection?

Piotr Rieske
1, 2

  1. Zakład Biologii Nowotworów, Uniwersytet Medyczny w Łodzi
  2. Celther Polska
Alergologia Polska – Polish Journal of Allergology 2020; 7, 3: 131–145
Online publish date: 2020/08/05
View full text Get citation
 
PlumX metrics:
Article offers analysis of main aspects of SARS-CoV-2/COVID-19 vaccination (severe acute respiratory syndrome coronavirus 2/COVID-19-Coronavirus Disease 2019). Optimal vaccine should protect not only against disease COVID-19 (symptoms), but also against SARS-CoV-2 infection (spreading disease). However, this kind of vaccine – showing highest safety level is extremely difficult to get. Several additional SARS-CoV-2/COVID-19 vaccination issues were addressed in article. For example: serological passports, herd immunity, clinical trials, and role of antibodies and T cells crossreactivities. Article discusses some issues related to vaccination responsibilities.
keywords:

SARS-CoV-2, vaccine, COVID-19



Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.